Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myasthenia Gravis (MG)”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06106672
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis

Who this might be right for
Myasthenia GravisGeneralized MyastheniaAChR Myasthenia Gravis+1 more
COUR Pharmaceutical Development Company, Inc. 54
Early research (Phase 1)Not Yet RecruitingNCT07676266
What this trial is testing

C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Multiple Sclerosis (MS)Myasthenia Gravis (MG)Neuromyelitis Optica Spectrum Disorder+3 more
The Affiliated Hospital of Qingdao University 18
Early research (Phase 1)Looking for participantsNCT07085676
What this trial is testing

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

Who this might be right for
Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)Rheumatoid Arthritis (RA)+6 more
Polina Stepensky 120
Not applicableNot Yet RecruitingNCT07499323
What this trial is testing

Talquetamab in Patients With Refractory Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis (MG)
First Affiliated Hospital of Chongqing Medical University 2
Not applicableLooking for participantsNCT06259071
What this trial is testing

MuSK Myasthenia 1000 Study

Who this might be right for
Myasthenia GravisMuSK MGMuSK Myasthenia Gravis
George Washington University 1,000
Not applicableNot Yet RecruitingNCT07571525
What this trial is testing

Thymic Disease, Autoimmunity, and Neuromuscular Junction Integrity in Myasthenia Gravis

Who this might be right for
Myasthenia Gravis (MG)Myasthenia Gravis Associated With ThymomaThymoma
IRCCS San Raffaele 40
Not applicableStudy completedNCT05380128
What this trial is testing

Association Study Between VDR Gene Polymorphisms and Risk and Features of MG in Han Chinese Population

Who this might be right for
Myasthenia Gravis, OcularGene Polymorphism
Beijing Tongren Hospital 297
Large-scale testing (Phase 3)Study completedNCT00294658
What this trial is testing

Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy

Who this might be right for
Myasthenia Gravis
University of Alabama at Birmingham 126
Large-scale testing (Phase 3)Study completedNCT02774239
What this trial is testing

A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG)

Who this might be right for
Myasthenia Gravis
University of Alberta 26
Testing effectiveness (Phase 2)Looking for participantsNCT06359041
What this trial is testing

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis (gMG)
Cabaletta Bio 24
Early research (Phase 1)Active Not RecruitingNCT06220201
What this trial is testing

Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

Who this might be right for
Multiple SclerosisMyasthenia Gravis
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT04146051
What this trial is testing

Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)

Who this might be right for
Myasthenia Gravis, Generalized
Cartesian Therapeutics 30
Testing effectiveness (Phase 2)Study completedNCT03863080
What this trial is testing

RVT-1401 in Myasthenia Gravis (MG) Patients

Who this might be right for
Myasthenia Gravis
Immunovant Sciences GmbH 17
Large-scale testing (Phase 3)Study completedNCT00309088
What this trial is testing

FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients

Who this might be right for
Myasthenia Gravis
Astellas Pharma Inc 80
Testing effectiveness (Phase 2)Looking for participantsNCT07673744
What this trial is testing

Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)

Who this might be right for
Myasthenia Gravis
TG Therapeutics, Inc. 120
Early research (Phase 1)Looking for participantsNCT06626919
What this trial is testing

Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

Who this might be right for
Muscular DiseasesNeuromuscular ManifestationsAutoimmune+4 more
Arcellx, Inc. 30
Not applicableNot Yet RecruitingNCT07226830
What this trial is testing

Quantification of Change in MG Disease Activity in Individuals With Generalized Myasthenia Gravis (gMG) After Administration of VYVGART® or VYVGART Hytrulo® Using BioDigit MG

Who this might be right for
Myasthenia Gravis Generalized
BioSensics 25
Not applicableStudy completedNCT01927692
What this trial is testing

Therapeutic Plasma Exchange in MG

Who this might be right for
Myasthenia Gravis
Duke University 11
Large-scale testing (Phase 3)Study completedNCT00309101
What this trial is testing

An Open Study for Steroid Resistant, Non-Thymectomized MG Patients

Who this might be right for
Myasthenia Gravis
Astellas Pharma Inc 11
Early research (Phase 1)Looking for participantsNCT06680037
What this trial is testing

Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

Who this might be right for
B-cell Mediated Autoimmune Disorders
TG Therapeutics, Inc. 100
Next Page